References
- Stein PD, Alpert JS, Bussey HI, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001;119:220S–7
- Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492–501
- Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on Antithrombotic and Thrombolytic therapy. Chest 2004;126:401S–28
- Shetty HG, Fennerty AG, Routledge PA. Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokinet 1989;16:238–53
- Ansell JE, Hirsch J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on Antithrombotic and Thrombolytic therapy. Chest 2004;126:204S–33
- Fihn SD, Mc Donell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: A multicenter study. Ann Intern Med 1993;118:511–20
- Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348:423–8
- Casais P, Sanchez-Luceros A, Meschengieser SS, et al. Bleeding risk factors in chronic oral anticoagulation with acenocoumarol. Am J Hematol 2000;63:192–6
- Cannegetier SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;47:525–30
- Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996;132:1095–100
- Chiquette E, Amateo MG, Bussey HI. Comparison of an anticoagulation clinic and usual medical care: anticoagulation control, patient outcomes and health care costs. Arch Intern Med 1998;158:641–7
- Spertus JA, Jones P, McDonell M, et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 2002;106:43–9
- Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003;290:215–21
- Lancaster TR, Singer DE, Sheehan MA, et al. The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med 1991;151:1944–9
- Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: A case-control study. Am J Med 1997;103:11–7
- Barcellona D, Contu P, Sorano GG, et al. The management of oral anticoagulant therapy: the patient’s point of view. Thromb Haemost 2000;83:49–53
- Samsa G, Matchar DB, Dolor RJ, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes 2004;2:22
- Medical Outcomes Trust. How to Score the SF-36 Health Survey. Medical Outcomes Trust, Boston, MA, second printing, January, 1994
- Tang EO, Lai CS, Lee KK, et al. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother 2003;37:34–9
- Ferrer M, Alonso J, Morera J, et al. Chronic Obstructive Pulmonary Disease stage and health related quality of life. The quality of life of chronic obstructive pulmonary disease Study Group. Ann Int Med 1997;127:1072–9
- Rocco MV, Gassman JJ, Wang SR, et al. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: The modification of diet in renal disease study. Am J Kidney Dis 1997;29:888–96
- Jaffary F, Khan T, Kamali F, et al. The effect of stability of oral anticoagulant therapy upon patient-perceived health status and quality of life. J Am Geriatr Soc 2003;51:885–7